Role of clip markers placed by endoscopic ultrasonography in contouring gross tumor volume for thoracic esophageal squamous cell carcinoma: one prospective study

被引:4
|
作者
Guan, Yong [1 ]
Wang, Jing [1 ]
Cao, Fuliang [2 ]
Chen, Xi [1 ]
Wang, Yuwen [1 ]
Jiang, Shengpeng [1 ]
Zhang, Daguang [1 ]
Zhang, Wencheng [1 ]
Guo, Zhoubo [1 ]
Wang, Ping [1 ]
Pang, Qingsong [1 ]
机构
[1] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Canc Preventing & Therapy, Tianjins Clin Res Ctr Canc,Dept Radiotherapy, Tianjin, Peoples R China
[2] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Canc Preventing & Therapy, Tianjins Clin Res Ctr Canc,Dept Endoscopy, Tianjin, Peoples R China
关键词
Esophageal cancer; endoscopic ultrasonography (EUS); titanium clip; radiotherapy; gross tumor volume (GTV); GUIDED FIDUCIAL PLACEMENT; RADIATION-THERAPY; RADIOTHERAPY; CANCER; IMPACT; EUS; TOMOGRAPHY; ULTRASOUND; PET; CT;
D O I
10.21037/atm-20-4030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: We aimed to analyze the value of metal clip markers guided and placed by endoscopic ultrasonography (EUS) in the delineation of gross tumor volume (GTV) for thoracic esophageal squamous cell carcinoma. Methods: From September 2016 to September 2018, patients with thoracic esophageal squamous cell carcinoma in Tianjin Medical University Cancer Institute and Hospital were recruited in the prospective trial, NCT02959385. They underwent titanium clips placement on tumor superior and inferior boundaries under EUS by a single expert endosonographer before radiotherapy computed tomography (CT) simulation. According to the clip markers, the reference GTVs were contoured by one experienced radiation oncologist. With the help of the Eclipse treatment planning system, clip markers on CT were concealed. Afterward, two other radiation oncologists with expertise in esophageal cancer delineated GTVs, defined as conventional GTVs, based on endoscopy and barium radiography findings. The two GTVs were compared and analyzed. Subgroup analysis was conducted in different T stage [early (T1 + T2) vs. advanced (T3 + T4)], focus location (upper vs. middle vs. lower segment), and tumor length (<5 vs. >5 cm) groups. Results: The trial recruited 55 patients with 60 thoracic esophageal cancer foci. A total of 111 titanium clips were guided and implanted by EUS. Before CT simulation, two titanium clips at two foci fell off. After the procedure, no case of intolerable esophageal pain, hemorrhage, or perforation occurred. Compared to reference GTVs, discrepancies of conventional GTVs superior borders were 0.91 +/- 0.82 cm (P<0.001), while differences of inferior borders were 0.74 +/- 0.63 cm (P<0.001). On the contrary, conventional GTVs lengths were not significantly different from reference GTVs with discrepancies 0.08 +/- 1.30 cm (P=0.64). Regardless of T stage, tumor location, and tumor length, conventional GTVs superior and inferior borders were significantly different from reference GTVs, while GTVs lengths differed insignificantly. Conclusions: This study confirmed that EUS-placed titanium clips could correct contouring of GTVs in thoracic esophageal cancer in different T stages, tumor locations, and lengths.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] A novel quantitative model based on gross tumor volume corresponding to anatomical distribution measured with multidetector computed tomography to determine the resectability of non-distant metastatic esophageal squamous cell carcinoma
    Gao, Dan
    Ou, Jing
    Tan, Bang-Guo
    Yu, Zi-Yi
    Li, Ke-Ying
    Li, Rui
    Zhang, Xiao-Ming
    Chen, Tian-Wu
    Zhou, Hai-Ying
    ONCOLOGY LETTERS, 2023, 26 (05)
  • [42] Potential role of circulating tumor cells and cell-free DNA as biomarkers in oral squamous cell carcinoma: A prospective single-center study
    Eboshida, Natsuki
    Hamada, Atsuko
    Higaki, Mirai
    Obayashi, Fumitaka
    Ito, Nanako
    Yamasaki, Sachiko
    Tani, Ryouji
    Shintani, Tomoaki
    Koizumi, Koichi
    Yanamoto, Souichi
    PLOS ONE, 2024, 19 (12):
  • [43] Serial Circulating Tumor DNA for Evaluating Early Response During Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: Preliminary Analysis of a Prospective Biomarker Study
    Wang, X.
    Zhang, T.
    Deng, L.
    Wang, W.
    Liu, W., Jr.
    Wang, J.
    Zhai, Y. R.
    Feng, Q.
    Lv, J.
    Xiao, Z.
    Chen, D.
    Zhou, Z.
    Bi, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S84 - S85
  • [44] Circulating tumor DNA serial monitoring of relapse and responses to tislelizumab immunotherapy as second-line monotherapy for metastatic esophageal squamous cell carcinoma: A prospective study
    He, Qiong
    Shi, Xun
    Yan, Junrong
    Wu, Mengmeng
    Gu, Cuiping
    Yu, Xinmin
    MOLECULAR AND CLINICAL ONCOLOGY, 2024, 20 (04)
  • [45] Gross Tumor Volume Definition and Comparative Assessment for Esophageal Squamous Cell Carcinoma From 3D 18F-FDG PET/CT by Deep Learning-Based Method
    Yue, Yaoting
    Li, Nan
    Shahid, Husnain
    Bi, Dongsheng
    Liu, Xin
    Song, Shaoli
    Ta, Dean
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [46] Skill-up study of systemic endoscopic examination technique using narrow band imaging of the head and neck region of patients with esophageal squamous cell carcinoma: Prospective multicenter study
    Okamoto, Naoki
    Morimoto, Hiroyuki
    Yamamoto, Yoichi
    Kanda, Keisuke
    Nankinzan, Rino
    Kasamatsu, Shingo
    Yoshimura, Shigenobu
    Kan, Motoyasu
    Nakano, Akira
    Hosaka, Shosuke
    Watanabe, Yuuka
    Arahata, Kyoko
    Toyama, Yuzo
    Okamura, Ayumi
    Yamaguchi, Taketo
    Yano, Tomonori
    DIGESTIVE ENDOSCOPY, 2019, 31 (06) : 653 - 661
  • [47] Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)
    Ding, Chengzhi
    Guo, Yijun
    Zhou, Yaning
    He, Yi
    Chen, Chunji
    Zhang, Ming
    Guo, Xufeng
    BMC CANCER, 2023, 23 (01)
  • [48] Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)
    Chengzhi Ding
    Yijun Guo
    Yaning zhou
    Yi He
    Chunji Chen
    Ming Zhang
    Xufeng Guo
    BMC Cancer, 23
  • [49] The optimal threshold of 18F-FLT PET and 18F-FDG PET to estimate the length of gross tumor volume in patients with squamous cell carcinoma of the thoracic esophagus verified by pathological examination
    Yu, J., Sr.
    Han, D.
    Zhong, Xiaojun
    Mu, Dianbin
    Fu, Zheng
    Zhang, Baijiang
    Zhang, Limin
    Zhang, Weidi
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [50] Tumor volume and cancer stem cell expression as prognostic markers for high-dose loco-regional failure in head and neck squamous cell carcinoma - A DAHANCA 19 study
    Kristensen, Morten Horsholt
    Sorensen, Mia Kristina
    Tramm, Trine
    Alsner, Jan
    Sorensen, Brita Singers
    Maare, Christian
    Johansen, Jorgen
    Primdahl, Hanne
    Bratland, Ase
    Kristensen, Claus Andrup
    Andersen, Maria
    Lilja-Fischer, Jacob Kinggaard
    Holm, Anne Ivalu Sander
    Samsoe, Eva
    Hansen, Christian Ronn
    Zukauskaite, Ruta
    Overgaard, Jens
    Eriksen, Jesper Grau
    RADIOTHERAPY AND ONCOLOGY, 2024, 193